Intelligence · Clinical Development
Pipeline search results
Programs matching “oncology” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 189 pipeline programs matching "oncology" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
64Cu(II)Cl2 solution for injection
A.C.O.M. - Advanced Center Oncology
Cancer on the prostatic bed
1 trial -
AG10
BridgeBio Oncology Therapeutics
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
1 trial -
ALXN2060
BridgeBio Oncology Therapeutics
Symptomatic Transthyretin Amyloid Cardiomyopathy
1 trial -
Acoramidis
BridgeBio Oncology Therapeutics
Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
1 trial -
Acoramidis
BridgeBio Oncology Therapeutics
Amyloidosis
3 trials -
Acoramidis (AG10)
BridgeBio Oncology Therapeutics
Amyloidosis in Transthyretin (TTR)
1 trial -
Acoramidis (AG10)
BridgeBio Oncology Therapeutics
Amyloid Cardiomyopathy, Transthyretin-Related
1 trial -
Arm A Mylotarg plus DA Versus CPX-351
Cardiff Oncology
Acute Myeloid Leukaemia
1 trial -
Azithromycin
Cardiff Oncology
Bronchopulmonary Dysplasia
1 trial -
BGJ398
BridgeBio Oncology Therapeutics
Advanced Cholangiocarcinoma
1 trial -
CG0070 Adenovirus Vector
CG Oncology
Transitional Cell Carcinoma
1 trial -
CHS-0214
Coherus Oncology
Rheumatoid Arthritis
1 trial -
CHS-1420
Coherus Oncology
Plaque Psoriasis
1 trial -
CISPLATIN, CARBOPLATIN
Cardiff Oncology
Human papillomavirus (HPV)-positive oropharyngeal cancer
1 trial -
CSET 2025/4132
The George Institute
Acute Myeloid Leukemia, ONCOLOGY
1 trial -
Cretostimogene Grenadenorepvec
CG Oncology
Non Muscle Invasive Bladder Cancer
2 trials -
E7777 9 mcg/kg
CITIUS ONCOLOGY, INC.
Persistent or Recurrent Cutaneous T-Cell Lymphoma
1 trial -
Encaleret
BridgeBio Oncology Therapeutics
Autosomal Dominant Hypocalcemia (ADH)
2 trials -
Encaleret
BridgeBio Oncology Therapeutics
Autosomal Dominant Hypocalcemia Type 1 (ADH1)
1 trial -
Etanercept
Coherus Oncology
Plaque Psoriasis
1 trial -
Etanercept
Coherus Oncology
Rheumatoid Arthritis
1 trial -
Evorpacept (ALX148)
ALX ONCOLOGY HOLDINGS INC
Gastric Cancer
1 trial -
GCAR-7213
Adaptive Biotechnologies Corp
Oncology - Glioblastoma (GBM)
1 trial -
Infigratinib
BridgeBio Oncology Therapeutics
Upper Tract Urothelial Carcinomas
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.